VIZZUTTI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.933
EU - Europa 5.157
AS - Asia 3.406
SA - Sud America 492
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 98
OC - Oceania 60
Totale 17.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.763
RU - Federazione Russa 1.534
IT - Italia 1.170
SG - Singapore 986
CN - Cina 838
PL - Polonia 820
HK - Hong Kong 479
BR - Brasile 379
SE - Svezia 370
VN - Vietnam 363
IE - Irlanda 354
KR - Corea 268
FI - Finlandia 198
DE - Germania 194
FR - Francia 149
BD - Bangladesh 108
UA - Ucraina 108
CA - Canada 102
GB - Regno Unito 100
IN - India 100
AU - Australia 60
JP - Giappone 51
JO - Giordania 49
CH - Svizzera 42
TR - Turchia 40
AR - Argentina 35
NL - Olanda 35
ID - Indonesia 30
MX - Messico 26
IQ - Iraq 23
ES - Italia 18
CO - Colombia 17
EC - Ecuador 17
CI - Costa d'Avorio 16
BE - Belgio 15
NG - Nigeria 15
PK - Pakistan 15
ZA - Sudafrica 14
EG - Egitto 12
RO - Romania 12
VE - Venezuela 12
CL - Cile 10
DZ - Algeria 9
KE - Kenya 9
PE - Perù 9
SC - Seychelles 8
GT - Guatemala 7
JM - Giamaica 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
LT - Lituania 5
NI - Nicaragua 5
NP - Nepal 5
SA - Arabia Saudita 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
CR - Costa Rica 4
IR - Iran 4
PT - Portogallo 4
TW - Taiwan 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
LV - Lettonia 3
PR - Porto Rico 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AT - Austria 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
PA - Panama 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MD - Moldavia 1
Totale 17.145
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.441
Ashburn 883
Warsaw 818
Singapore 690
Fairfield 665
Hong Kong 394
Chandler 391
Dublin 353
San Jose 320
Woodbridge 277
Cambridge 271
Seoul 267
Seattle 265
Milan 238
Houston 237
Wilmington 226
Hefei 182
Beijing 174
Jacksonville 162
Council Bluffs 139
Los Angeles 131
Ann Arbor 126
Florence 119
Ho Chi Minh City 109
Rome 109
Buffalo 100
The Dalles 100
Helsinki 95
Boardman 94
Lawrence 90
Hanoi 87
Altamura 86
Lauterbourg 83
Princeton 82
New York 72
Dallas 67
Moscow 65
Munich 60
Melbourne 58
Boston 53
Phoenix 47
São Paulo 47
Bern 42
Medford 42
Mumbai 41
Naples 36
San Diego 36
Columbus 34
Tokyo 33
Kent 32
Bologna 30
Paris 26
Shanghai 26
Frankfurt am Main 22
Da Nang 21
Jakarta 21
Toronto 21
Montreal 20
Izmir 19
London 19
Turin 19
Chicago 18
Turku 18
Abidjan 16
Ankara 16
Lappeenranta 16
Salt Lake City 16
Abuja 15
Brussels 15
Falls Church 15
Redondo Beach 15
Riverside 15
Chennai 14
Figino 14
Padua 14
Palermo 14
Haiphong 13
Shenzhen 12
Venice 12
Baghdad 11
Norwalk 11
Orem 11
San Francisco 11
Verona 11
Brooklyn 10
Dong Ket 10
Guangzhou 10
Sapporo 10
Atlanta 9
Bari 9
Cairo 9
Catania 9
Newark 9
Quito 9
Tianjin 9
Timisoara 9
Yubileyny 9
Amman 8
Andover 8
Bengaluru 8
Totale 11.281
Salva come PNG Salva come JPEG
Nome #
Consensus conference on TIPS management: Techniques, indications, contraindications 414
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 379
Acute on chronic liver failure: From pathophysiology to clinical management. 346
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 318
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 314
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 273
Anatomy and vascular biology of the cells in the portal circulation 263
Acute viral hepatitis increases liver stiffness values measured by transient elastography 242
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 234
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 234
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 229
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 227
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 221
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 219
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 217
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 213
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 213
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 208
ADMA correlates with portal pressure in patients with compensated cirrhosis. 208
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 205
Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. 201
Cellular and molecular basis of fibrogenesis in NASH 200
Farnesyltransferase inhibitor ABT-100 is a potent liver cancer chemopreventive agent 192
Ascites and hepatorenal syndrome 191
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 190
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 189
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 188
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis 187
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 182
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 180
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 180
Alcohol use disorder and liver transplant: new perspectives and critical issues 180
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 178
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 178
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 174
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 171
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 171
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 169
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 166
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice 163
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 162
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis. 162
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 161
Hepato-systemic gradient of carbon monoxide in cirrhosis. 160
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 160
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 159
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 154
Update on ascites and hepatorenal syndrome 153
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 152
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 152
Adipokines and liver fibrosis.Eur Rev Med Pharmacol 150
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 150
Trichobezoar causing gastric outlet obstruction in a patient with trichotillomania 148
Elastography for the non-invasive assessment of liver disease: limitations and future developments 148
Uveitis in autoimmune hepatitis: a case report. 148
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 148
Reply: Post-TIPS hemodynamic target adherence fails to improve outcomes in cirrhotic patients 145
Clinical evaluation of disease progression in chronic liver disease: towards an integrated system? 144
Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease. 142
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. 142
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 141
The Metabolic Syndrome and Chronic Liver Disease. 141
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach 138
Liver Stiffness, a non-invasive marker of liver disease: a core study group report. 138
PORTAL HYPERTENSION SECONDARY TO MYELOFIBROSIS A STUDY OF THREE CASES. 137
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 137
Management of a complex transjugular intrahepatic portosystemic shunt dysfunction with endotipsitis through rotational thrombectomy 135
EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION. 134
Fibrosis and cirrhosis reversibility: clinical features and implications 133
Reply to: Does encephalopathy with early onset after TIPS impact on mortality? 129
Non invasive diagnosis of portal hypertension in cirrhotic patients. 128
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 126
Etiology, management, and outcome of the Budd-Chiari syndrome. 125
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 124
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. 123
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 122
Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. 122
DIURETIC AND NATRIURETIC EFFECTS OF LONG-TERM ALBUMIN INFUSION IN PATIENTS WlTH CIRRHOSIS AND ASCITES: A RANDOMISED CONTROLLED STUDY 122
LIVER STIFFNESS MEASUREMENT (LSM) IS ABLE TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH HCV-RELATED ADVANCED CHRONIC LIVER DISEASE 119
Paradoxical embolization in TIPS: take a closer look to the heart. 118
Silybin, a component of sylimarin, exert anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells 118
Reply 116
Ruolo dell'elastografia transiente nell'identificazione della fibrosi in pazienti con epatopatia cronica HCV correlata 113
Impaired sympathetic regulation of cerebral blood flow in patients with cirrhosis of the liver. 113
Response to letter by R. Mookerjee and R. Jalan [2] 113
Editorial: Looking at Neptune with a binocular 112
 Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage. 111
Acites due to pericardial cyst 111
Reversible factors in portal hypertension. 110
Physical activity in liver transplant recipients: a large multicenter study 105
Letter on 'Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicentre Real-World' 104
Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion. 102
Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest. 2009 Nov 9. 101
Small diameter H-graft porta-caval shunt performed at different stages of liver disease 99
Baveno VIII – Advancing Consensus in Portal Hypertension 95
Reply 92
Evaluating the predictive performance of the elderly patient calculator TIPS score in a North American cohort 91
Technology insights: non invasive assessment of liver fibrosis by biochemical scores and elastography. 91
Response to letter by Mookerjee and Jalan 90
Reply to: “Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?” 89
Totale 16.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022515 0 0 38 20 22 28 31 27 34 42 114 159
2022/20231.635 146 267 56 136 119 288 215 94 196 13 49 56
2023/2024576 22 68 93 31 29 56 13 181 8 33 33 9
2024/20254.121 124 402 262 697 1.259 515 65 170 197 97 145 188
2025/20265.868 625 754 502 377 545 249 648 313 412 386 267 790
2026/2027805 260 317 228 0 0 0 0 0 0 0 0 0
Totale 17.247